PTX.AX
Price:
$0.048
Market Cap:
$38.66M
Prescient Therapeutics Limited, a clinical stage oncology company, develops novel drugs for the treatment of various cancers in Australia. Its lead drug candidate is PTX-200, which is in Phase 2a clinical trial for HER2-negative breast cancer, Phase IB/2 clinical trial in relapsed and refractory AML, and Phase 1b in recurrent or persistent platinum-resistant ovarian cancer; and PTX-100, a RhoA inhibitor, for hematological and solid malignancies that focuses on cancers with Ras and RhoA mutations. It has a strategic collaboration with The University of Texas MD Anderson Cancer Center to develop blood cancer binder for OmniCAR. The company was formerly known as Virax Holdings Limited and chang...[Read more]
Industry
Biotechnology
IPO Date
1999-01-03
Stock Exchange
ASX
Ticker
PTX.AX
According to Prescient Therapeutics Limited’s latest financial reports and current stock price. The company's current Current Ratio is 8.08. This represents a change of -38.30% compared to the average of 13.10 of the last 4 quarters.
The mean historical Current Ratio of Prescient Therapeutics Limited over the last ten years is 14.81. The current 8.08 Current Ratio has changed 5.36% with respect to the historical average. Over the past ten years (40 quarters), PTX.AX's Current Ratio was at its highest in in the December 2020 quarter at 80.10. The Current Ratio was at its lowest in in the March 2009 quarter at 0.
Average
14.81
Median
12.47
Minimum
3.48
Maximum
34.19
Discovering the peaks and valleys of Prescient Therapeutics Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 266.23%
Maximum Annual Current Ratio = 34.19
Minimum Annual Increase = -77.66%
Minimum Annual Current Ratio = 3.48
Year | Current Ratio | Change |
---|---|---|
2024 | 8.08 | -33.80% |
2023 | 12.21 | -30.68% |
2022 | 17.61 | -48.50% |
2021 | 34.19 | 239.46% |
2020 | 10.07 | -42.19% |
2019 | 17.42 | 43.08% |
2018 | 12.18 | -39.44% |
2017 | 20.11 | 57.96% |
2016 | 12.73 | 266.23% |
2015 | 3.48 | -77.66% |
The current Current Ratio of Prescient Therapeutics Limited (PTX.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
12.63
5-year avg
16.43
10-year avg
14.81
Prescient Therapeutics Limited’s Current Ratio is greater than Imugene Limited (3.86), less than Actinogen Medical Limited (13.91), greater than Patrys Limited (5.53), less than Antisense Therapeutics Limited (0), less than Immutep Limited (13.81),
Company | Current Ratio | Market cap |
---|---|---|
3.86 | $319.85M | |
13.91 | $78.32M | |
5.53 | $6.17M | |
0 | $52.29M | |
13.81 | $473.07M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Prescient Therapeutics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Prescient Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Prescient Therapeutics Limited's Current Ratio?
How is the Current Ratio calculated for Prescient Therapeutics Limited (PTX.AX)?
What is the highest Current Ratio for Prescient Therapeutics Limited (PTX.AX)?
What is the 3-year average Current Ratio for Prescient Therapeutics Limited (PTX.AX)?
What is the 5-year average Current Ratio for Prescient Therapeutics Limited (PTX.AX)?
How does the current Current Ratio for Prescient Therapeutics Limited (PTX.AX) compare to its historical average?